NCT07557563

Brief Summary

It is a prospective single-arm pilot study to investigate the safety and feasibility of flexible ureteroscopy under local anaesthesia.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
22mo left

Started Jun 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 29, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2028

Last Updated

May 5, 2026

Status Verified

April 1, 2026

Enrollment Period

1.6 years

First QC Date

April 22, 2026

Last Update Submit

April 29, 2026

Conditions

Upper Tract Urothelial Carcinoma

Outcome Measures

Primary Outcomes (1)

  • Procedure success rate

    The procedure is completed successfully.

    Immediately postoperatively

Secondary Outcomes (2)

  • Complication rate

    On day 30

  • Readmission rate

    On Day 30

Study Arms (1)

Treatment Arm

EXPERIMENTAL

Flexible ureterorenoscopy for Surveillance of UTUC under local anaesthesia

Other: Flexible ureterorenoscopy

Interventions

Flexible ureterorenoscopyOTHER

Flexible ureterorenoscopy for Surveillance of UTUC under local anaesthesia

Treatment Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older
  • Capable of giving informed consent
  • Having undergone an kidney-sparing surgery (endoscopic operation or segmental ureterectomy)

You may not qualify if:

  • Allergy to transurethral lidocaine jelly
  • On anticoagulation or anti-platelet medication with contraindications for cessation prior to the procedure
  • Structural abnormalities in the upper urinary tract on the intended side of examination

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prince of Wales Hospital

Hong Kong, Hong Kong

Location

Study Officials

  • Yuen Chun Jeremy TEOH, MD

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ho Ming Chris WONG, MBChB

CONTACT

35052625chriswong@surgery.cuhk.edu.hk

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 22, 2026

First Posted

April 29, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

March 31, 2028

Last Updated

May 5, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations

HK(1)